Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
Author ORCID Identifier
Date Available
5-17-2022
Year of Publication
2020
Document Type
Doctoral Dissertation
Degree Name
Doctor of Philosophy (PhD)
College
Medicine
Department/School/Program
Behavioral Science
Faculty
Dr. Timothy A. Butterfield
Faculty
Dr. Claire Clark
Faculty
Dr. Henry C. Vasconez
Abstract
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an emerging cancer of the immune system that can form around textured-surface breast implants. In this dissertation, the cellular and molecular mechanisms of BIA-ALCL are reviewed with a focus on the role of oncogenic JAK-STAT3 signaling in BIA-ALCL tumorigenesis and progression. Herein, the epidemiology of BIA-ALCL is systematically studied to better define the risk of BIA-ALCL and to determine the oncologic safety of smooth surface devices relative to BIA-ALCL formation. Next, a systematic review is conducted which critically appraises current clinical guidelines in order to establish an evidence base to better inform diagnosis and treatment. Finally, a molecular investigation is undertaken to determine the biological mechanisms of the disease which revealed pervasive upregulation of the JAK-STAT3 pathway as a key pathogenic feature in BIA-ALCL tumorigenesis. Herein, a novel mechanism of tumorigenesis via the JAK-STAT3 pathway is proposed—highlighting its potential mechanistic role. Collectively, the clinical research studies that comprise this dissertation demonstrate the oncologic safety of smooth-devices while illustrating substantial knowledge gaps in the risk of BIA-ALCL for commercially available textured breast devices in the U.S. market. This work also provides evidence-based recommendations and updates on diagnosis and treatment. Finally, this dissertation shows that BIA-ALCL tumorigenesis likely occurs through a novel mechanism that facilitates malignant transformation from a chronic inflammatory state through the JAK-STAT3 pathway.
Digital Object Identifier (DOI)
https://doi.org/10.13023/etd.2020.174
Funding Information
Dr. DeCoster was supported by a surgeon-scientist grant from the National Cancer Institute (T32CA160003). This work was partially supported by a research grant from the Southeastern Society of Plastic and Reconstructive Surgeons (2018-2019).
Recommended Citation
DeCoster, Ryan, "BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA: MOLECULAR FEATURES, EPIDEMIOLOGICAL RISK FACTORS, AND EVIDENCE-BASED CLINICAL RECOMMENDATIONS" (2020). Theses and Dissertations--Clinical and Translational Science. 11.
https://uknowledge.uky.edu/cts_etds/11
